Delivery Of A System For Automating The Mechanical-Enzymatic Dissociation Process Of Postoperative Tumors As Part Of The Project Entitled "Development Of The Drug-Predict Technology For Preclinical Prediction Of The Clinical Effectiveness Of Biologically Active Compounds In The Indication Of Colorectal And Pancreatic Cancer, Based On In Vitro And In Vivo Translational Preclinical Models Supported By An Ml Tool Enabling The Identification Of The Best Innovative Drug Candidates And Optimal Patient Groups", Financed By The National Center For Research And Development Under The European Funds For A Modern Economy 2021-2027 (Feng) Program. Financing Agreement No. Feng.01.01-Ip.01-A0Y3/25-00.